KRAS and lung carcinoma: Here we perform a genome-scale analysis using KRAS-mutant human pancreatic and lung cancer cell lines to investigate whether knock-down or overexpression of mutant KRAS as well as pharmacological inhibtion of ERK correlates with differential DNA methylation.